Gadolinium(III) ion (Gd3+) (Gd3+)

Gadolinium(III) ion (Gd3+) is a trivalent lanthanide metal ion primarily utilized in clinical medicine as the active paramagnetic component of magnetic resonance imaging (MRI) contrast agents (StatPearls, 2023). Due to its seven unpaired electrons, Gd3+ effectively shortens the longitudinal relaxation time (T1) of nearby water protons, significantly enhancing the contrast and clarity of diagnostic images (Radiopaedia, 2024). In physiological and research settings, free Gd3+ is known to be a potent, non-specific inhibitor of various ion channels, particularly mechanosensitive (stretch-activated) channels and voltage-gated calcium channels, by physically occluding the channel pore (PubMed, 1991). Because free gadolinium is highly toxic to biological systems, it is administered in the form of stable chelates, such as gadopentetate or gadoterate, to facilitate safe renal clearance (NIH, 2022). However, exposure to certain gadolinium-based contrast agents (GBCAs) has been linked to Nephrogenic Systemic Fibrosis (NSF) in patients with severe renal dysfunction and to long-term deposition in brain and bone tissues (FDA, 2017). Consequently, while Gd3+ is not a traditional therapeutic target, its pharmacological management and safety profile are critical areas of concern in radiology and nephrology (Journal of Magnetic Resonance Imaging, 2018). The ion's ability to mimic calcium ions allows it to interfere with numerous calcium-dependent processes, which underlies its toxicity in the free state (PubChem, 2024). Research continues into the development of more stable macrocyclic chelates to further reduce the risk of ion dissociation and subsequent tissue accumulation (EMA, 2018).

Other names

Gadolinium ionGd(III)Gadolinium(3+)Lanthanide ion

Gadolinium(III) ions function as MRI contrast agents by shortening the T1 relaxation time of water protons through paramagnetic interaction (StatPearls, 2023). Biologically, they act as non-specific blockers of mechanosensitive and voltage-gated calcium channels by physically obstructing the ion conduction pore (PubMed, 1991).